SB-4826
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SB-4826, covering 2026-03-05 to 2026-03-05. Get the full timeline:
Most recent: Clinical Trial Update: SB-4826 in Adult Participants With Locally Advanced or Metastatic Solid Tumors or Non-Hodgkin Lymphomas [Phase 1, Phase 2]